Meadow Creek Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Sell
8,030
-93
-1% -$21.7K 1.25% 17
2026
Q1
$1.99M Buy
8,123
+354
+5% +$82.5K 1.28% 16
2025
Q4
$1.61M Buy
7,769
+491
+7% +$97.1K 1.03% 21
2025
Q3
$1.4M Buy
7,278
+326
+5% +$55.9K 0.93% 22
2025
Q2
$1.06M Sell
6,952
-302
-4% -$46.4K 0.72% 30
2025
Q1
$1.2M Buy
7,254
+606
+9% +$94.8K 0.9% 27
2024
Q4
$961K Buy
6,648
+60
+0.9% +$9.3K 0.69% 35
2024
Q3
$1.07M Buy
6,588
+685
+12% +$109K 0.85% 30
2024
Q2
$863K Sell
5,903
-1,800
-23% -$268K 0.82% 30
2024
Q1
$1.22M Buy
7,703
+13
+0.2% +$2.07K 0.85% 30
2023
Q4
$1.21M Buy
+7,690
New +$1.18M 1.17% 18
2022
Q3
$1.09M Buy
6,656
+121
+2% +$20.5K 1.44% 8
2022
Q2
$1.16M Buy
6,535
+536
+9% +$95.5K 1.43% 7
2022
Q1
$1.06M Sell
5,999
-2,152
-26% -$366K 1.15% 11
2021
Q4
$1.39M Buy
+8,151
New +$1.33M 1.32% 11
2019
Q4
$765K Buy
+5,241
New +$711K 1.06% 17

Other funds holding JNJ

Meadow Creek Wealth Advisors's JNJ Position: Q2 2026 in Review

Meadow Creek Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 1.1% in Q2 2026, selling an estimated $21.7K and leaving 8,030 shares worth $2.04M. The position accounts for 1.25% of the portfolio, ranked #17.

Meadow Creek Wealth Advisors first reported a position in JNJ in Q4 2019 and has held it in 16 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Meadow Creek Wealth Advisors held 8,030 shares of Johnson & Johnson worth $2.04M as of Q2 2026.
  • Meadow Creek Wealth Advisors sold 93 Johnson & Johnson shares in Q2 2026, an estimated $21.7K.
  • Johnson & Johnson made up 1.25% of Meadow Creek Wealth Advisors's portfolio in Q2 2026, its #17 holding.
  • Meadow Creek Wealth Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 16 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Meadow Creek Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.